1. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) / S. Moe [et al.] // Kidney Int. – 2006. – Vol. 69, N 11. – P. 1945–1953. https://doi.org/10.1038/sj.ki.5000414

2. Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem / F. C. Barreto [et al.] // Kidney Int. – 2006. – Vol. 69, N 10. – P. 1852–1857. https://doi.org/10.1038/sj.ki.5000311

3. Chronic kidney disease – mineral-bone disorder: a new paradigm / S. Moe [et al.] // Adv. Chron. Kidney Dis. – 2007. – Vol. 14, N 1. – P. 3–12. https://doi.org/10.1053/j.ackd.2006.10.005

4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) // Kidney Int. Suppl. – 2017. – Vol. 7, N 1. – P. 1–59. https://doi.org/10.1016/j.kisu.2017.10.001

5. Moe, S. M. Renal osteodystrophy or kidney-induced osteoporosis? / S. M. Moe // Curr. Osteoporos. Rep. – 2017. – Vol. 15, N 3. – P. 194–197. https://doi.org/10.1007/s11914-017-0364-1

6. Hsu, C.-Y. Osteoporosis in patients with chronic kidney diseases: a systemic review / C.-Y. Hsu, L.-R. Chen, K.-H. Chen // Int. J. Mol. Sci. – 2020. – Vol. 21, N 18, art. 6846. https://doi.org/10.3390/ijms21186846

7. Osteoporosis, bone mineral density and CKD-MBD complex (I): Diagnostic considerations / J. Bover [et al.] // Nefrologia (Engl. ed). – 2018. – Vol. 38, N 5. – P. 476–490. https://doi.org/10.1016/j.nefro.2017.12.006

8. McNerny, E. M. B. Bone quality in chronic kidney disease: definitions and diagnostics / E. M. B. McNerny, T. L. Nickolas // Curr. Osteoporos. Rep. – 2017. – Vol. 15, N 3. – P. 207–213. https://doi.org/10.1007/s11914-017-0366-z

9. A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease / G. Hampson [et al.] // Endocrine. – 2021. – Vol. 73, N 3. – P. 509–529. https://doi.org/10.1007/s12020-021-02735-9

10. European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D / P. Evenepoel [et al.] // Nephrol. Dialys. Transplant. – 2021. – Vol. 36, N 1. – P. 42–59. https://doi.org/10.1093/ndt/gfaa192

11. Карлович, Н. В. Вторичный гиперпаратиреоз при хронической болезни почек / Н. В. Карлович, Т. В. Мохорт ; УО БГМУ. – Минск, 2021. – 177 с.

12. European guidance for the diagnosis and management of osteoporosis in postmenopausal women / J. A. Kanis [et al.] // Osteoporos. Int. – 2019. – Vol. 30, N 1. – P. 3–44. https://doi.org/10.1007/s00198-018-4704-5

13. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy / S. Mazzaferro [et al.] // Nephrol. Dial. Transplant. – 1995. – Vol. 10, N 1. – P. 52–58. https://doi.org/10.1093/oxfordjournals.ndt.a090853

14. Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry / A. Ferreira [et al.] // J. Nephrol. – 2009. – Vol. 22, N 6. – P. 783–793.

15. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients / S. Okuno [et al.] // Osteoporos. Int. – 2005. – Vol. 16, N 5. – P. 501–509. https://doi.org/10.1007/s00198-004-1712-4

16. The non-invasive diagnosis of bone disorders in CKD / J. Bover [et al.] // Calcif. Tissue Int. – 2021. – Vol. 108, N 4. – P. 512–527. https://doi.org/10.1007/s00223-020-00781-5

17. Evaluation of biochemical markers and bone mineral density in patients with chronic kidney disease stage 5D at the start of hemodialysis treatment / I. Valkovsky [et al.] // Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. – 2015. – Vol. 159, N 1. – P. 93–99. https://doi.org/10.5507/bp.2013.087

18. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis / H. H. Malluche [et al.] // Clin. J. Am. Soc. Nephrol. – 2014. – Vol. 9, N 7. – P. 1254–1262. https://doi.org/10.2215/CJN.09470913

19. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients / D. L. Regidor [et al.] // J. Am. Soc. Nephrol. – 2008. – Vol. 19, N 11. – P. 2193–2203. https://doi.org/10.1681/ASN.2008010014

20. Определение референтного интервала паратгормона у пациентов с различными стадиями хронической болезни почек / Н. В. Карлович [и др.] // Вес. Нац. акад. навук Беларусі. Сер. мед. навук. – 2020. – Т. 19, № 2. – C. 186–194.

21. The 7th Official Positions of the International Society for Clinical Densitometry – ADULTS. – Mode of access: http:// https://iscd.org/learn/official-positions/adult-positions. – Date of access: 26.02.2022.

22. Predictors of bone mineral density in patients on hemodialysis / D. Zayour [et al.] // Transplant Proc. – 2004. – Vol. 36, N 5. – P. 1297–1301. https://doi.org/10.1016/j.transproceed.2004.05.069